Patents by Inventor Nobuo Nomura
Nobuo Nomura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10984989Abstract: A charge neutralizer that includes a vacuum chamber which is capable of having a charged object installed therein and includes a high vacuum processing unit that performs vapor deposition, and a plasma generator configured to supply plasma caused by an electron cyclotron resonance to an inside of the vacuum chamber. The plasma generator includes a plasma source configured to generate the plasma, and a flange configured to install the plasma source inside the vacuum chamber.Type: GrantFiled: November 28, 2018Date of Patent: April 20, 2021Inventors: Nobuo Nomura, Tomofumi Mogami, Kazuki Minemura, Daiki Koda, Takato Morishita, Satoshi Hosoda, Hitoshi Kuninaka
-
Publication number: 20200279722Abstract: A charge neutralizer that includes a vacuum chamber which is capable of having a charged object installed therein and includes a high vacuum processing unit that performs vapor deposition, and a plasma generator configured to supply plasma caused by an electron cyclotron resonance to an inside of the vacuum chamber. The plasma generator includes a plasma source configured to generate the plasma, and a flange configured to install the plasma source inside the vacuum chamber.Type: ApplicationFiled: November 28, 2018Publication date: September 3, 2020Inventors: Nobuo NOMURA, Tomofumi MOGAMI, Kazuki MINEMURA, Daiki KODA, Takato MORISHITA, Satoshi HOSODA, Hitoshi KUNINAKA
-
Patent number: 10232026Abstract: Disclosed is a vaccine which has a high therapeutic effect on mycoplasma infection and is highly safe. For the purpose of developing effective therapeutic methods for mycoplasma infection, mycoplasma-mimic particles which are effective as a vaccine for mycoplasma infection are provided, and also provided are bacterium-mimic particles including common bacteria. Bacterium-mimic particles such as mycoplasma-mimic particles can be provided by producing liposome particles in which a lipid antigen specific to a pathogenic bacterium such as mycoplasma is contained as a liposome-constituting lipid component. The administration of the mycoplasma-mimic particles enables the induction of a potent immunological activity in living bodies. The mycoplasma-mimic particles can be used as an excellent vaccine for the prevention or treatment of mycoplasma infection.Type: GrantFiled: December 13, 2016Date of Patent: March 19, 2019Assignees: NATIONAL INSTITUTE OF INFECTIOUS DISEASES, M BIO TECHNOLOGY INC.Inventors: Kazuhiro Matsuda, Koji Ichiyama, Sachie Matsuda, Yuko Sasaki, Yoshichika Arakawa, Ryo Harasawa, Yoshihiro Nishida, Norio Katayama, Yasuo Endo, Nobuo Nomura
-
Publication number: 20170165343Abstract: Disclosed is a vaccine which has a high therapeutic effect on mycoplasma infection and is highly safe. For the purpose of developing effective therapeutic methods for mycoplasma infection, mycoplasma-mimic particles which are effective as a vaccine for mycoplasma infection are provided, and also provided are bacterium-mimic particles including common bacteria. Bacterium-mimic particles such as mycoplasma-mimic particles can be provided by producing liposome particles in which a lipid antigen specific to a pathogenic bacterium such as mycoplasma is contained as a liposome-constituting lipid component. The administration of the mycoplasma-mimic particles enables the induction of a potent immunological activity in living bodies. The mycoplasma-mimic particles can be used as an excellent vaccine for the prevention or treatment of mycoplasma infection.Type: ApplicationFiled: December 13, 2016Publication date: June 15, 2017Applicants: NATIONAL INSTITUTE OF INFECTIOUS DISEASES, M BIO TECHNOLOGY INC.Inventors: Kazuhiro Matsuda, Koji Ichiyama, Sachie Matsuda, Yuko Sasaki, Yoshichika Arakawa, Ryo Harasawa, Yoshihiro Nishida, Norio Katayama, Yasuo Endo, Nobuo Nomura
-
Patent number: 9539209Abstract: Disclosed is a vaccine which has a high therapeutic effect on mycoplasma infection and is highly safe. For the purpose of developing effective therapeutic methods for mycoplasma infection, mycoplasma-mimic particles which are effective as a vaccine for mycoplasma infection are provided, and also provided are bacterium-mimic particles including common bacteria. Bacterium-mimic particles such as mycoplasma-mimic particles can be provided by producing liposome particles in which a lipid antigen specific to a pathogenic bacterium such as mycoplasma is contained as a liposome-constituting lipid component. The administration of the mycoplasma-mimic particles enables the induction of a potent immunological activity in living bodies. The mycoplasma-mimic particles can be used as an excellent vaccine for the prevention or treatment of mycoplasma infection.Type: GrantFiled: June 4, 2010Date of Patent: January 10, 2017Assignees: NATIONAL INSTITUTE OF INFECTIOUS DISEASES, M BIO TECHNOLOGY INC.Inventors: Kazuhiro Matsuda, Koji Ichiyama, Sachie Matsuda, Yuko Sasaki, Yoshichika Arakawa, Ryo Harasawa, Yoshihiro Nishida, Norio Katayama, Yasuo Endo, Nobuo Nomura
-
Publication number: 20120135067Abstract: Disclosed is a vaccine which has a high therapeutic effect on mycoplasma infection and is highly safe. For the purpose of developing effective therapeutic methods for mycoplasma infection, mycoplasma-mimic particles which are effective as a vaccine for mycoplasma infection are provided, and also provided are bacterium-mimic particles including common bacteria. Bacterium-mimic particles such as mycoplasma-mimic particles can be provided by producing liposome particles in which a lipid antigen specific to a pathogenic bacterium such as mycoplasma is contained as a liposome-constituting lipid component. The administration of the mycoplasma-mimic particles enables the induction of a potent immunological activity in living bodies. The mycoplasma-mimic particles can be used as an excellent vaccine for the prevention or treatment of mycoplasma infection.Type: ApplicationFiled: June 4, 2010Publication date: May 31, 2012Applicants: M BIO TECHNOLOGY INC., NATIONAL INSTITUTE OF INFECTIOUS DISEASESInventors: Kazuhiro Matsuda, Koji Ichiyama, Sachie Matsuda, Yuko Sasaki, Yoshichika Arakawa, Ryo Harasawa, Yoshihiro Nishida, Norio Katayama, Yasuo Endo, Nobuo Nomura
-
Patent number: 7829083Abstract: A novel gene apparently encoding a transmembrane glycoprotein has been successfully isolated by constructing a cDNA library of 4 kb or above in size from mRNA expressed in human adult brain and analyzing the structures of the cDNAs contained within said library by the shotgun method. The novel gene shows brain-specific expression and the protein encoded by said gene has a typical PDZ binding motif.Type: GrantFiled: January 11, 2008Date of Patent: November 9, 2010Assignees: Chugai Seiyaku Kabushiki Kaisha, Kazusa DNA Research InstituteInventors: Takahiro Nagase, Shoji Miyata, Nobuo Nomura, Osamu Ohara, Shin-ichi Funahashi
-
Publication number: 20090258022Abstract: A novel gene apparently encoding a transmembrane glycoprotein has been successfully isolated by constructing a cDNA library of 4 kb or above in size from mRNA expressed in human adult brain and analyzing the structures of the cDNAs contained within said library by the shotgun method. The novel gene shows brain-specific expression and the protein encoded by said gene has a typical PDZ binding motif.Type: ApplicationFiled: January 11, 2008Publication date: October 15, 2009Applicants: CHUGAI SEIYAKU KABUSHIKI KAISHA, KAZUSA DNA RESEARCH INSTITUTEInventors: Shin-ichi Funahashi, Shoji Miyata, Nobuo Nomura, Takahiro Nagase, Osamu Ohara
-
Patent number: 7344838Abstract: A novel gene apparently encoding a transmembrane glycoprotein has been successfully isolated by constructing a cDNA library of 4 kb or above in size from mRNA expressed in human adult brain and analyzing the structures of the cDNAs contained within said library by the shotgun method. The novel gene shows brain-specific expression and the protein encoded by said gene has a typical PDZ binding motif.Type: GrantFiled: December 7, 2004Date of Patent: March 18, 2008Assignees: Chugai Seiyaku Kabushiki Kaisha, Kazusa DNA Research InstituteInventors: Shin-Ichi Funahashi, Shoji Miyata, Nobuo Nomura, Takahiro Nagase, Osamu Ohara
-
Publication number: 20050079539Abstract: A novel gene apparently encoding a transmembrane glycoprotein has been successfully isolated by constructing a cDNA library of 4 kb or above in size from mRNA expressed in human adult brain and analyzing the structures of the cDNAs contained within said library by the shotgun method. The novel gene shows brain-specific expression and the protein encoded by said gene has a typical PDZ binding motif.Type: ApplicationFiled: December 7, 2004Publication date: April 14, 2005Inventors: Shin-Ichi Funahashi, Shoji Miyata, Nobuo Nomura, Takahiro Nagase, Osamu Ohara
-
Patent number: 6852836Abstract: A novel gene apparently encoding a transmembrane glycoprotein has been successfully isolated by constructing a cDNA library of 4 kb or above in size from mRNA expressed in human adult brain and analyzing the structures of cDNAs contained within said library by the shotgun method. The novel gene shows brain-specific expression and the protein encoded by said gene has a typical PDZ protein binding motif.Type: GrantFiled: November 18, 1999Date of Patent: February 8, 2005Assignees: Chugai Sieyaku Kabushiki Kaisha, Kazusa DNA Research InstituteInventors: Shin-Ichi Funahashi, Shoji Miyata, Nobuo Nomura, Takahiro Nagase, Osamu Ohara
-
Patent number: 6790944Abstract: The present invention relates to a novel protein isolated from the leukocyte of IgA nephropathy patients, and DNA encoding the protein. It also relates to an oligonucleotide based on the nucleotide sequence complementary with the DNA, an antibody which specifically reacts with the protein and, furthermore, diagnostic and therapeutic drugs of IgA nephropathy comprising it.Type: GrantFiled: August 5, 1998Date of Patent: September 14, 2004Assignees: Kyowa Hakko Kogyo Co., Ltd., Kazusa DNA Research Institute FoundationInventors: Tetsuyoshi Ishiwata, Mikiko Sakurada, Ayako Kawabata, Satoshi Nakagawa, Tetsuro Kuga, Tatsunari Nishi, Nobuo Nomura, Takahiro Nagase, Shigemasa Sawada, Masami Takei
-
Publication number: 20040142445Abstract: This invention provides a novel metalloprotease having an aggrecanase activity which causes joint diseases, a gene coding for this metalloprotease, a promoter of the above metalloprotease, a method for screening a drug with the use of the above metalloprotease and a pharmaceutical composition for inhibiting degradation of proteoglycans, which comprises as the active ingredient a substance capable of inhibiting the aggrecanase activity of the above metalloprotease.Type: ApplicationFiled: January 26, 2004Publication date: July 22, 2004Applicants: YAMANOUCHI PHARMACEUTICAL CO., LTD., KAZUSA DNA RESEARCH INSTITUTEInventors: Noboru Yamaji, Kouichi Nishimura, Kunitake Abe, Osamu Ohara, Takahiro Nagase, Nobuo Nomura
-
Patent number: 6716613Abstract: This invention provides a novel metalloprotease having an aggrecanase activity which causes joint diseases, a gene coding for this metalloprotease, a promoter of the above metalloprotease, a method for screening a drug with the use of the above metalloprotease and a pharmaceutical composition for inhibiting degradation of proteoglycans, which comprises as the active ingredient a substance capable of inhibiting the aggrecanase activity of the above metalloprotease.Type: GrantFiled: December 10, 2001Date of Patent: April 6, 2004Assignees: Yamanouchi Pharmaceutical Co., Ltd., Kazusa DNA Research InstituteInventors: Noboru Yamaji, Kouichi Nishimura, Kunitake Abe, Osamu Ohara, Takahiro Nagase, Nobuo Nomura
-
Publication number: 20040040053Abstract: The present invention provides materials and methods for the rapid cloning and mutagenesis of nucleic acid molecules. The present invention permits simultaneous introduction of a one or more point mutations and adapter sequences into a nucleic acid of interest.Type: ApplicationFiled: November 22, 2002Publication date: February 26, 2004Inventors: Nobuo Nomura, Naoki Goshima, Yasutomo Kisu, Saki Sono
-
Patent number: 5895632Abstract: The invention provides a discharging method by which charge can be removed readily, uniformly and efficiently from a surface of a working object even where the surface has a complicated charge pattern of a large number of small positive and negative charged portions present closely to each other at random in a mixed condition. A working object is passed between a positive and negative ion producing discharging electrode and an ion attracting electrode opposed to the positive and negative ion producing discharging electrode and having a face extending in a travelling direction of the working object and a perpendicular direction. During such passage, high positive and negative voltages are applied alternately to the positive and negative ion producing discharging electrode to alternately produce positive and negative ions.Type: GrantFiled: March 28, 1997Date of Patent: April 20, 1999Assignee: Kasuga Denki, IncorporatedInventors: Nobuo Nomura, Fumiyoshi Shimizu
-
Patent number: 5683556Abstract: The invention provides a discharging method by which charges can be removed readily, uniformly and efficiently from a surface of a working object even where the surface has a complicated charge pattern of a large number of small positive and negative charged portions present closely to each other at random in a mixed condition. A working object is passed between a positive and negative ion producing discharging electrode and an ion attracting electrode opposed to the positive and negative ion producing discharging electrode and having a face extending in a travelling direction of the working object and a perpendicular direction. During such passage, high positive and negative voltages are applied alternately to the positive and negative ion producing discharging electrode to alternately produce positive and negative ions.Type: GrantFiled: September 27, 1995Date of Patent: November 4, 1997Assignee: Kasuga Denki, IncorporatedInventors: Nobuo Nomura, Fumiyoshi Shimizu
-
Patent number: 5471615Abstract: A distributed data processing system is provided in which two computers, each running under a different operating system, are coupled so that jobs initiated by a first one of the computers can be executed on a second computer by using the resources of the second computer. This enables the user of the first computer to use the second computer under the environment of the first computer. The first computer acts as the interface between the user and the data processing system. Service programs running on the system can handle or provide for input/output operations during the execution of jobs on the second computer so that the jobs seem to the user of the first computer to be executed on the first computer. The system has means for creating a dummy file in the file system of one operating system which is used as a place holder for a corresponding file in a storage device attached to the other operating system, and accessed by programs controlled by that other operating system.Type: GrantFiled: June 22, 1994Date of Patent: November 28, 1995Assignee: International Business Machines CorporationInventors: Keiji Amatsu, Zenhachiroh Butoh, Hiroshi Hirai, Minoru Massaki, Hirofumi Morita, Takeo Nakajima, Nobuo Nomura, Mikio Sakaki, Stephen J. Schmandt, Katsuhiro Tanaka